These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 36397325)

  • 1. Covid-19 vaccine effectiveness during Omicron BA.2 pandemic in Shanghai: A cross-sectional study based on EMR.
    Xu S; Sun M
    Medicine (Baltimore); 2022 Nov; 101(45):e31763. PubMed ID: 36397325
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CoronaVac and BBIBP-CorV vaccines against SARS-CoV-2 during predominant circulation of Omicron BA.5.2 and BF.7 in China, a retrospective cohort study.
    Hu Z; Jin Z; Zhou M; Zhang C; Bao Y; Gao X; Wang G
    J Med Virol; 2023 Oct; 95(10):e29143. PubMed ID: 37814963
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Risk of hospitalization and vaccine effectiveness among COVID-19 patients in the UAE during the Delta and Omicron outbreaks.
    Albreiki M; Mousa M; Azman SK; Vurivi H; Alhalwachi Z; Alshehhi F; AlShamsi S; Marzouqi NA; Alawadi T; Alrand H; Oulhaj A; Fikri A; Alsafar H
    Front Immunol; 2023; 14():1049393. PubMed ID: 36860855
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Actual Status of Hospitals as COVID-19 Vaccination Clinics in China and Safety Monitoring of Inactivated Vaccine: A Cross-Sectional Study.
    Huang J; Zhang MQ; Huang MZ; Lin GM
    Disaster Med Public Health Prep; 2022 Aug; 17():e256. PubMed ID: 36017705
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of the Sinopharm's BBIBP-CorV vaccine in preventing hospital admissions and death in infected vaccinees: Results from a retrospective study in the emirate of Abu Dhabi, United Arab Emirates (UAE).
    Ismail AlHosani F; Eduardo Stanciole A; Aden B; Timoshkin A; Najim O; Abbas Zaher W; AlSayedsaleh AlDhaheri F; Al Mazrouie S; Rizvi TA; Mustafa F
    Vaccine; 2022 Mar; 40(13):2003-2010. PubMed ID: 35193793
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Analysis of COVID-19 Incidence and Severity Among Adults Vaccinated With 2-Dose mRNA COVID-19 or Inactivated SARS-CoV-2 Vaccines With and Without Boosters in Singapore.
    Ng OT; Marimuthu K; Lim N; Lim ZQ; Thevasagayam NM; Koh V; Chiew CJ; Ma S; Koh M; Low PY; Tan SB; Ho J; Maurer-Stroh S; Lee VJM; Leo YS; Tan KB; Cook AR; Tan CC
    JAMA Netw Open; 2022 Aug; 5(8):e2228900. PubMed ID: 36018588
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Real-world study of the effectiveness of BBIBP-CorV (Sinopharm) COVID-19 vaccine in the Kingdom of Morocco.
    Zhang Y; Belayachi J; Yang Y; Fu Q; Rodewald L; Li H; Yan B; Wang Y; Shen Y; Yang Q; Mu W; Tang R; Su C; Xu T; Obtel M; Mhayi A; Razine R; Abouqal R; Zhang Y; Yang X
    BMC Public Health; 2022 Aug; 22(1):1584. PubMed ID: 35987605
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The impact of vaccination on patients with COVID-19 during the wave of Omicron in Shanghai.
    Yu C; Fengzhao Z; Hongmei W; Zeyuan L; Yu L; Yuhang G; Rufei S; Qingzhu J; Xiaorong S; Xia W; Caiping S; Zhi X; Chunmei L
    Front Public Health; 2022; 10():1054313. PubMed ID: 36438303
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Technical guidelines for seasonal influenza vaccination in China (2022-2023)].
    National Immunization Advisory Committee (NIAC) Technical Working Group (TWG) on Influenza Vaccination
    Zhonghua Yu Fang Yi Xue Za Zhi; 2022 Oct; 56(10):1356-1386. PubMed ID: 36274602
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effectiveness and Cost-Effectiveness of Inactivated Vaccine to Address COVID-19 Pandemic in China: Evidence From Randomized Control Trials and Real-World Studies.
    Fu Y; Zhao J; Wei X; Han P; Yang L; Ren T; Zhan S; Li L
    Front Public Health; 2022; 10():917732. PubMed ID: 35928479
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effectiveness of adenovirus type 5 vectored and inactivated COVID-19 vaccines against symptomatic COVID-19, COVID-19 pneumonia, and severe COVID-19 caused by the B.1.617.2 (Delta) variant: Evidence from an outbreak in Yunnan, China, 2021.
    Ma C; Sun W; Tang T; Jia M; Liu Y; Wan Y; Han J; Rodewald L; Li J; Song Y; Wang Y; Wu D; Wang F; Zheng H; Tang L; Gao GF; Yin Z; An Z
    Vaccine; 2022 May; 40(20):2869-2874. PubMed ID: 35400561
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effectiveness of 2, 3, and 4 COVID-19 mRNA Vaccine Doses Among Immunocompetent Adults During Periods when SARS-CoV-2 Omicron BA.1 and BA.2/BA.2.12.1 Sublineages Predominated - VISION Network, 10 States, December 2021-June 2022.
    Link-Gelles R; Levy ME; Gaglani M; Irving SA; Stockwell M; Dascomb K; DeSilva MB; Reese SE; Liao IC; Ong TC; Grannis SJ; McEvoy C; Patel P; Klein NP; Hartmann E; Stenehjem E; Natarajan K; Naleway AL; Murthy K; Rao S; Dixon BE; Kharbanda AB; Akinseye A; Dickerson M; Lewis N; Grisel N; Han J; Barron MA; Fadel WF; Dunne MM; Goddard K; Arndorfer J; Konatham D; Valvi NR; Currey JC; Fireman B; Raiyani C; Zerbo O; Sloan-Aagard C; Ball SW; Thompson MG; Tenforde MW
    MMWR Morb Mortal Wkly Rep; 2022 Jul; 71(29):931-939. PubMed ID: 35862287
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Technical guidelines for seasonal influenza vaccination in China (2022-2023)].
    National Immunization Advisory Committee (NIAC) Technical Working Group (TWG), Influenza Vaccination TWG
    Zhonghua Liu Xing Bing Xue Za Zhi; 2022 Oct; 43(10):1515-1544. PubMed ID: 36456484
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effectiveness of BNT162b2 and CoronaVac vaccinations against mortality and severe complications after SARS-CoV-2 Omicron BA.2 infection: a case-control study.
    Yan VKC; Wan EYF; Ye X; Mok AHY; Lai FTT; Chui CSL; Li X; Wong CKH; Li PH; Ma T; Qin S; Wong VKC; Tsang TC; Tsui SH; Chui WCM; Cowling BJ; Leung GM; Lau CS; Wong ICK; Chan EWY
    Emerg Microbes Infect; 2022 Dec; 11(1):2304-2314. PubMed ID: 35980089
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vaccination coverage among COVID-19 prevention and control management teams at primary healthcare facilities in China and their attitudes towards COVID-19 vaccine: a cross-sectional online survey.
    Yan YY; Wang HT; Fan TY; Sun XJ; Du ZH; Sun XM
    BMJ Open; 2022 Apr; 12(4):e056345. PubMed ID: 35393315
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vaccination Is Associated With Shorter Time to Target Cycle Threshold Value in Patients With SARS-CoV-2 Omicron Variant.
    Wu J; Wei Y; Shen F; Zhu S; Lu Y; Tian X; Zhang P
    Front Cell Infect Microbiol; 2022; 12():943407. PubMed ID: 35873164
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Acceptance of seasonal influenza vaccination and associated factors among pregnant women in the context of COVID-19 pandemic in China: a multi-center cross-sectional study based on health belief model.
    Wang R; Tao L; Han N; Liu J; Yuan C; Deng L; Han C; Sun F; Chi L; Liu M; Liu J
    BMC Pregnancy Childbirth; 2021 Nov; 21(1):745. PubMed ID: 34732157
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunogenicity, durability, and safety of an mRNA and three platform-based COVID-19 vaccines as a third dose following two doses of CoronaVac in China: A randomised, double-blinded, placebo-controlled, phase 2 trial.
    Zhang Y; Ma X; Yan G; Wu Y; Chen Y; Zhou Z; Wan N; Su W; Liu FW; Dai MX; Yang M; Li C; Yu X; Zhang L; Wang Z; Zhou TC; You D; Wei J; Zhang Z;
    EClinicalMedicine; 2022 Dec; 54():101680. PubMed ID: 36188435
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Acceptance of a vaccine against pandemic influenza A (H1N1) virus amongst healthcare workers in Beijing, China.
    Seale H; Kaur R; Wang Q; Yang P; Zhang Y; Wang X; Li X; Zhang H; Zhang Z; MacIntyre CR
    Vaccine; 2011 Feb; 29(8):1605-10. PubMed ID: 21211593
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Influenza Vaccine Effectiveness Against 2009 Pandemic Influenza A(H1N1) Virus Differed by Vaccine Type During 2013-2014 in the United States.
    Gaglani M; Pruszynski J; Murthy K; Clipper L; Robertson A; Reis M; Chung JR; Piedra PA; Avadhanula V; Nowalk MP; Zimmerman RK; Jackson ML; Jackson LA; Petrie JG; Ohmit SE; Monto AS; McLean HQ; Belongia EA; Fry AM; Flannery B
    J Infect Dis; 2016 May; 213(10):1546-56. PubMed ID: 26743842
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.